ISSN: 2329-9096
+44 1300 500008
Department of Neurology, The University of Alabama at Birmingham, 1530, 3rd Avenue S, Birmingham, AL 35294, USA
Mini Review
Amifampridines (3,4 Diaminopyridine and 3,4 Diaminopyridine Phosphate): Drugs of Choice for Lambert-Eaton Myasthenic Syndrome
Author(s): Shin J Oh*
Amifampridines have been known to be effective as symptomatic treatment of Lambert-Eaton myasthenic syndrome
since 1983. Food Drug Administration (FDA) approved amifampridines, the most studied safe and effective drugs in
the neuromuscular diseases, are available for the general use for symptomatic treatment of LEMS, 60 years after the
first description of LEMS and 40 years after the first trial of 3,4-DAP in LEMS... View More»
DOI:
10.35248/2329-9096.21.s4.005